Blackfeet Community College
Browning, Montana, 59417, United States
Location status: Recruiting
Location contact
Betty Henderson-Matthews, MA
CONTACT
406-338-5441 ext. 2800
Betty Henderson-Matthews, MA
PRINCIPAL_INVESTIGATOR
NCT Number: NCT06878885
Volunteers for the study are asked to participate in two laboratory sessions. In the first laboratory session, volunteers are asked to provide a blood sample which will be used to measure factors related to health. Participants also complete questionnaires related to demographic and health-related information and undergo evaluations of their body composition. In the second laboratory visit, participants are asked to have cardiovascular, neuroendocrine, and inflammatory activity measured during a brief period of rest and during a short challenging psychological task. Participants will also complete questionnaires. The study is designed to examine the associations between experiences such as trauma and resiliency with changes in bodily systems during a challenge and current health.
Interested in participating?
Request Info18 year–40 year
All sexes
Interventional
Not applicable
Browning, Montana, 59417, United States
Location status: Recruiting
Betty Henderson-Matthews, MA
CONTACT
406-338-5441 ext. 2800
Betty Henderson-Matthews, MA
PRINCIPAL_INVESTIGATOR
This cross-sectional study will examine the association between factors of resiliency and trauma with physiological (cardiovascular, neuroendocrine, inflammatory) responses to acute stress and current mental and physical health. Study volunteers will include individuals who identify as American Indian and currently live on and near the Blackfeet Reservation. Study volunteers will be asked to provide information that will be used to measure: correlates of cardiometabolic and mental health, acute psychological stress, arterial stiffness. Results of the study will help increase knowledge of cardiometabolic and mental health in the context of past and ongoing trauma and resiliency.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Volunteers will complete a 4-minute Paced Auditory Serial Addition Task which is a standardized laboratory challenge that is widely used to monitor cardiovascular, neuroendocrine, and inflammatory responses in the laboratory.
Time frame: 10 minute resting baseline mean will be subtracted from the 4 minute task period for each value
The mean systolic blood pressure (mmHg) will be subtracted from the mean of the task period.
Time frame: 10 minute resting baseline mean will be subtracted from the 4 minute task period for each value
The mean diastolic blood pressure (mmHg) will be subtracted from the mean of the task period.
Time frame: 10 minute resting baseline mean will be subtracted from the 4 minute task period for each value
The mean heart rate (bpm) will be subtracted from the mean of the task period.
Time frame: Baseline will be subtracted from the peak (15 minutes after task onset, 35 minute task onset)
Salivary samples will be taken to measure cortisol (nmol/L) the mean from the peak stress period will be subtracted from the baseline
Time frame: Baseline will be subtracted from the level 30 minutes after task onset.
IL-6 (pg/mL) measured at baseline will be subtracted from the IL-6 measured post task.
Time frame: 5 minutes
Pulse wave velocity in m/s will be assessed by dual impedance cardiography as a non-invasive indicator of arterial stiffness. This measure will be derived from the 5 minute baseline period.
Time frame: 10 minutes
Resting systolic blood pressure (mmHg)
Time frame: 10 minutes
Resting diastolic blood pressure (mmHg)
Time frame: 5 minutes
Circulating levels of C-reactive protein, interleukin-6, tumor necrosis factor-a, monocyte chemoattractant protein-1, interleukin-1b, interleukin-10, and adiponectin will be assessed via a blood draw. A composite score will be created.
Time frame: 5 minutes
Hemoglobin A1c (nmol/L) will be assessed via blood draw
Time frame: 5 minutes
Glucose (nmol/L) will be assessed via blood draw
Time frame: 5 minutes
Insulin (mL) will be assessed via blood draw
Time frame: 5 minutes
Total cholesterol (mg) will be assessed via blood draw
Time frame: 5 minutes
Low-density lipoprotein (mg/dL) will be assessed via blood draw
Time frame: 5 minutes
high-density lipoprotein (mg/dL) will be assessed via blood draw
Time frame: 5 minutes
Triglycerides (mmol/L) will be assessed via blood draw
Time frame: 2 minutes
Waist circumference
Time frame: 2 minutes
Hip circumference
Time frame: 10 minutes
Hospital Anxiety Depression Questionnaire (depression subscale)
Time frame: 10 minutes
PHQ-9
Time frame: 5 minutes
Hospital Anxiety Depression Questionnaire (Anxiety subscale)
Time frame: 10 minutes
Alcohol use will be assessed using the Alcohol Use Identification Test
Time frame: 5 minutes
A cumulative score of substance use will be reported by indicating the number of recreational drugs "ever" tried
Contact information is provided by the study sponsor or research team.
Annie Ginty, PhD
CONTACT
Neha John-Henderson, PhD
CONTACT
Montana State University
Other
Acronym: IHPIPO'TO'TSP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07391072
Behavior, Behavioral Symptoms
Almere Stad, Flevoland, Netherlands
View Trial DetailsNCT07291713
Activities of Daily Living, Adverse Childhood Experience
Taipei, Taiwan
View Trial DetailsNCT07109973
Adolescent Depression, Anxiety Disorder
Ras al-Khaimah, United Arab Emirates
View Trial DetailsNCT06840184
Behavior, Behavioral Symptoms
Rawalpindi, Punjab Province, Pakistan
View Trial Details